Mapping the scientific research on atypical antipsychotic drugs in Spain: A bibliometric assessment

Francisco López-Muñoz, Gabriel Rubio, Juan D. Molina, Winston W. Shen, Miguel A. Pérez-Nieto, Raquel Moreno, Lorena Huelves, Concha Noriega, Pilar Garcia-Garcia, Cecilio Álamo

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Objectives: We carried out a bibliometric study on the scientific publications in relation to atypical antipsychotic drugs (AADs) in Spain. Methods: We used the EMBASE and MEDLINE databases and we applied some bibliometric indicators of paper production and dispersion (Price's law and Bradford's law, respectively). We also calculated the participation index of the different countries and correlated the bibliometric data with some social and health data (total per capita expenditure on health and gross domestic expenditure on research and development). Results: We collected 656 original papers published between 1988 and 2011. Our study results fulfilled Price's law with scientific production on AADs showing exponential growth (correlation coefficient r= 0.9693, vs. r= 0.9177 after linear adjustment). The most widely studied drugs were risperidone (181 papers), olanzapine (143), clozapine (94), and quetiapine (74). Division into Bradford zones yielded a nucleus occupied by the European Psychiatry and European Neuropsychopharmacology (70 articles). Totally 194 different journals were published, with 5 of the first 10 used journals having an impact factor being greater than 4. Conclusion: The publications on AADs in Spain have undergone exponential growth over the studied period, without evidence of reaching a saturation point.

Original languageEnglish
Pages (from-to)349-360
Number of pages12
JournalActas Espanolas de Psiquiatria
Volume41
Issue number6
Publication statusPublished - Nov 2013

Fingerprint

Bibliometrics
Spain
Antipsychotic Agents
olanzapine
Health Expenditures
Publications
Journal Impact Factor
Research
Social Adjustment
Risperidone
Clozapine
Growth
MEDLINE
Psychiatry
Databases
Health
Pharmaceutical Preparations

Keywords

  • Atypical antipsychotics
  • Bibliometry
  • Bipolar disorder
  • Schizophrenia
  • Spain

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

López-Muñoz, F., Rubio, G., Molina, J. D., Shen, W. W., Pérez-Nieto, M. A., Moreno, R., ... Álamo, C. (2013). Mapping the scientific research on atypical antipsychotic drugs in Spain: A bibliometric assessment. Actas Espanolas de Psiquiatria, 41(6), 349-360.

Mapping the scientific research on atypical antipsychotic drugs in Spain : A bibliometric assessment. / López-Muñoz, Francisco; Rubio, Gabriel; Molina, Juan D.; Shen, Winston W.; Pérez-Nieto, Miguel A.; Moreno, Raquel; Huelves, Lorena; Noriega, Concha; Garcia-Garcia, Pilar; Álamo, Cecilio.

In: Actas Espanolas de Psiquiatria, Vol. 41, No. 6, 11.2013, p. 349-360.

Research output: Contribution to journalReview article

López-Muñoz, F, Rubio, G, Molina, JD, Shen, WW, Pérez-Nieto, MA, Moreno, R, Huelves, L, Noriega, C, Garcia-Garcia, P & Álamo, C 2013, 'Mapping the scientific research on atypical antipsychotic drugs in Spain: A bibliometric assessment', Actas Espanolas de Psiquiatria, vol. 41, no. 6, pp. 349-360.
López-Muñoz F, Rubio G, Molina JD, Shen WW, Pérez-Nieto MA, Moreno R et al. Mapping the scientific research on atypical antipsychotic drugs in Spain: A bibliometric assessment. Actas Espanolas de Psiquiatria. 2013 Nov;41(6):349-360.
López-Muñoz, Francisco ; Rubio, Gabriel ; Molina, Juan D. ; Shen, Winston W. ; Pérez-Nieto, Miguel A. ; Moreno, Raquel ; Huelves, Lorena ; Noriega, Concha ; Garcia-Garcia, Pilar ; Álamo, Cecilio. / Mapping the scientific research on atypical antipsychotic drugs in Spain : A bibliometric assessment. In: Actas Espanolas de Psiquiatria. 2013 ; Vol. 41, No. 6. pp. 349-360.
@article{04495a1ffd5943b99325dcacf99cbfb0,
title = "Mapping the scientific research on atypical antipsychotic drugs in Spain: A bibliometric assessment",
abstract = "Objectives: We carried out a bibliometric study on the scientific publications in relation to atypical antipsychotic drugs (AADs) in Spain. Methods: We used the EMBASE and MEDLINE databases and we applied some bibliometric indicators of paper production and dispersion (Price's law and Bradford's law, respectively). We also calculated the participation index of the different countries and correlated the bibliometric data with some social and health data (total per capita expenditure on health and gross domestic expenditure on research and development). Results: We collected 656 original papers published between 1988 and 2011. Our study results fulfilled Price's law with scientific production on AADs showing exponential growth (correlation coefficient r= 0.9693, vs. r= 0.9177 after linear adjustment). The most widely studied drugs were risperidone (181 papers), olanzapine (143), clozapine (94), and quetiapine (74). Division into Bradford zones yielded a nucleus occupied by the European Psychiatry and European Neuropsychopharmacology (70 articles). Totally 194 different journals were published, with 5 of the first 10 used journals having an impact factor being greater than 4. Conclusion: The publications on AADs in Spain have undergone exponential growth over the studied period, without evidence of reaching a saturation point.",
keywords = "Atypical antipsychotics, Bibliometry, Bipolar disorder, Schizophrenia, Spain",
author = "Francisco L{\'o}pez-Mu{\~n}oz and Gabriel Rubio and Molina, {Juan D.} and Shen, {Winston W.} and P{\'e}rez-Nieto, {Miguel A.} and Raquel Moreno and Lorena Huelves and Concha Noriega and Pilar Garcia-Garcia and Cecilio {\'A}lamo",
year = "2013",
month = "11",
language = "English",
volume = "41",
pages = "349--360",
journal = "Actas Espanolas de Psiquiatria",
issn = "1139-9287",
publisher = "STM Editores S.A",
number = "6",

}

TY - JOUR

T1 - Mapping the scientific research on atypical antipsychotic drugs in Spain

T2 - A bibliometric assessment

AU - López-Muñoz, Francisco

AU - Rubio, Gabriel

AU - Molina, Juan D.

AU - Shen, Winston W.

AU - Pérez-Nieto, Miguel A.

AU - Moreno, Raquel

AU - Huelves, Lorena

AU - Noriega, Concha

AU - Garcia-Garcia, Pilar

AU - Álamo, Cecilio

PY - 2013/11

Y1 - 2013/11

N2 - Objectives: We carried out a bibliometric study on the scientific publications in relation to atypical antipsychotic drugs (AADs) in Spain. Methods: We used the EMBASE and MEDLINE databases and we applied some bibliometric indicators of paper production and dispersion (Price's law and Bradford's law, respectively). We also calculated the participation index of the different countries and correlated the bibliometric data with some social and health data (total per capita expenditure on health and gross domestic expenditure on research and development). Results: We collected 656 original papers published between 1988 and 2011. Our study results fulfilled Price's law with scientific production on AADs showing exponential growth (correlation coefficient r= 0.9693, vs. r= 0.9177 after linear adjustment). The most widely studied drugs were risperidone (181 papers), olanzapine (143), clozapine (94), and quetiapine (74). Division into Bradford zones yielded a nucleus occupied by the European Psychiatry and European Neuropsychopharmacology (70 articles). Totally 194 different journals were published, with 5 of the first 10 used journals having an impact factor being greater than 4. Conclusion: The publications on AADs in Spain have undergone exponential growth over the studied period, without evidence of reaching a saturation point.

AB - Objectives: We carried out a bibliometric study on the scientific publications in relation to atypical antipsychotic drugs (AADs) in Spain. Methods: We used the EMBASE and MEDLINE databases and we applied some bibliometric indicators of paper production and dispersion (Price's law and Bradford's law, respectively). We also calculated the participation index of the different countries and correlated the bibliometric data with some social and health data (total per capita expenditure on health and gross domestic expenditure on research and development). Results: We collected 656 original papers published between 1988 and 2011. Our study results fulfilled Price's law with scientific production on AADs showing exponential growth (correlation coefficient r= 0.9693, vs. r= 0.9177 after linear adjustment). The most widely studied drugs were risperidone (181 papers), olanzapine (143), clozapine (94), and quetiapine (74). Division into Bradford zones yielded a nucleus occupied by the European Psychiatry and European Neuropsychopharmacology (70 articles). Totally 194 different journals were published, with 5 of the first 10 used journals having an impact factor being greater than 4. Conclusion: The publications on AADs in Spain have undergone exponential growth over the studied period, without evidence of reaching a saturation point.

KW - Atypical antipsychotics

KW - Bibliometry

KW - Bipolar disorder

KW - Schizophrenia

KW - Spain

UR - http://www.scopus.com/inward/record.url?scp=84893050726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893050726&partnerID=8YFLogxK

M3 - Review article

C2 - 24203507

AN - SCOPUS:84893050726

VL - 41

SP - 349

EP - 360

JO - Actas Espanolas de Psiquiatria

JF - Actas Espanolas de Psiquiatria

SN - 1139-9287

IS - 6

ER -